GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexicon Pharmaceuticals Inc (STU:LX31) » Definitions » Cyclically Adjusted PB Ratio

Lexicon Pharmaceuticals (STU:LX31) Cyclically Adjusted PB Ratio : 1.97 (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Lexicon Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Lexicon Pharmaceuticals's current share price is €4.096. Lexicon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €2.08. Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.97.

The historical rank and industry rank for Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:LX31' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.4   Med: 1.69   Max: 4.13
Current: 1.43

During the past years, Lexicon Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 4.13. The lowest was 0.40. And the median was 1.69.

STU:LX31's Cyclically Adjusted PB Ratio is ranked better than
55.22% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs STU:LX31: 1.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lexicon Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was €1.079. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lexicon Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexicon Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Lexicon Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.56 1.66 2.20 1.28 1.24

Lexicon Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.71 1.68 0.84 1.24 1.96

Competitive Comparison of Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Lexicon Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.096/2.08
=1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexicon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Lexicon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.079/131.7762*131.7762
=1.079

Current CPI (Mar. 2024) = 131.7762.

Lexicon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.168 100.560 1.531
201409 0.821 100.428 1.077
201412 2.226 99.070 2.961
201503 2.298 99.621 3.040
201506 1.990 100.684 2.605
201509 1.702 100.392 2.234
201512 2.532 99.792 3.344
201603 2.188 100.470 2.870
201606 1.863 101.688 2.414
201609 1.586 101.861 2.052
201612 1.431 101.863 1.851
201703 1.196 102.862 1.532
201706 0.896 103.349 1.142
201709 0.623 104.136 0.788
201712 0.546 104.011 0.692
201803 0.201 105.290 0.252
201806 -0.041 106.317 -0.051
201809 -0.238 106.507 -0.294
201812 -0.219 105.998 -0.272
201903 -0.380 107.251 -0.467
201906 -0.540 108.070 -0.658
201909 1.407 108.329 1.712
201912 0.992 108.420 1.206
202003 0.463 108.902 0.560
202006 -0.089 108.767 -0.108
202009 0.639 109.815 0.767
202012 0.908 109.897 1.089
202103 0.887 111.754 1.046
202106 0.788 114.631 0.906
202109 0.780 115.734 0.888
202112 0.675 117.630 0.756
202203 0.563 121.301 0.612
202206 0.448 125.017 0.472
202209 0.771 125.227 0.811
202212 0.586 125.222 0.617
202303 0.434 127.348 0.449
202306 0.702 128.729 0.719
202309 0.534 129.860 0.542
202312 0.349 129.419 0.355
202403 1.079 131.776 1.079

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lexicon Pharmaceuticals  (STU:LX31) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lexicon Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexicon Pharmaceuticals (STU:LX31) Business Description

Traded in Other Exchanges
Address
2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Lexicon Pharmaceuticals (STU:LX31) Headlines

No Headlines